Secretary Michael Leavitt, Department of Health and Human Services
   Next »
 
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
J. Brian Munroe, Past President & Chairman, PMC; Capitol Hill Group (left), HHS Secretary Michael O. Leavitt (center), Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals (right)
Edward Abrahams, Executive Director, Personalized Medicine Coalition
Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals
Secretary Michael Leavitt, Department of Health and Human Services (left) and Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals (right)
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services
Secretary Michael Leavitt, Department of Health and Human Services (left) and Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals (right)
Raju Kucherlapati, Harvard-Partners Center for Genetics and Genomics
Tim McCaffrey, The George Washington University Medical Center
Secretary Michael Leavitt, Department of Health and Human Services (left) and Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals (right)
Wayne A. Rosenkrans, Jr. , President & Chairman, PMC; Business Strategy Director, External Scientific Affairs, AstraZeneca Pharmaceuticals
Edward Abrahams, Personalized Medicine Coalition (left) and Raju Kucherlapati, Harvard-Partners Center for Genetics and Genomics (right)
Raju Kucherlapati, Harvard-Partners Center for Genetics and Genomics (left) and Robert Wells, Affymetrix, Inc.
Charles Kennedy, WellPoint, Inc. (left) and Raymond Woosley, The Critical Path Institute (right)
Sharon Terry, PMC Board Member; Genetic Alliance; Coalition for Genetic Fairness
Francis Collins, NHGRI (left) and Reed Tuckson, UnitedHealth Group (right)
Francis Collins, NHGRI (left) and Reed Tuckson, UnitedHealth Group (right)
Sheila Walcoff, Department of Health and Human Services (left) and James Greenwood, BIO (right)
Robert Croyle, NCI (left) and Brett Davis, PMC Board Member; IBM Healthcare and Life Sciences
Francis Collins, NHGRI (right)
Scott Bowen, Centers for Disease Control and Prevention (left); Bradley Perkins, Centers for Disease Control and Prevention (center)
J. Brian Munroe, PMC Board Member; Capitol Hill Group (left); Drew Fromkin, Clinical Data, Inc. (center); Charles Kennedy, WellPoint, Inc. (right)
Reed Tuckson, UnitedHealth Group (left) and James Greenwood, BIO (right)
Lisa Olson, Cheney Cardiovascular Institute at The George Washington University (left) and Edward Abrahams, Personalized Medicine Coalition (right)